Day One Biopharmaceuticals, Inc. Share Price
DAWNDay One Biopharmaceuticals, Inc. Stock Performance
Open $10.30 | Prev. Close $10.35 | Circuit Range N/A |
Day Range $10.04 - $10.41 | Year Range $5.63 - $15.91 | Volume 1,09,637 |
Average Traded $10.19 |
Day One Biopharmaceuticals, Inc. Share Price Chart
About Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
Day One Biopharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $10.30 | $10.13 | +0.00% |
12-Nov-25 | $10.30 | $10.13 | -2.27% |
11-Nov-25 | $10.15 | $10.36 | +2.07% |
10-Nov-25 | $9.90 | $10.15 | +4.26% |
07-Nov-25 | $9.05 | $9.73 | +8.53% |
06-Nov-25 | $9.10 | $8.97 | -1.75% |
05-Nov-25 | $8.04 | $9.13 | +24.90% |